Salwa

550 total citations
26 papers, 380 citations indexed

About

Salwa is a scholar working on Pharmaceutical Science, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Salwa has authored 26 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Salwa's work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Analytical Methods in Pharmaceuticals (4 papers). Salwa is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Analytical Methods in Pharmaceuticals (4 papers). Salwa collaborates with scholars based in India, United States and Malaysia. Salwa's co-authors include Lalit Kumar, Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Ruchi Verma, Yanhong Duo, Lalitkumar K. Vora, Ben Zhong Tang, Nidhi Raval, Vivek P. Chavda and Vandana Patravale and has published in prestigious journals such as Journal of Controlled Release, International Journal of Biological Macromolecules and Nano Today.

In The Last Decade

Salwa

26 papers receiving 375 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Salwa 132 126 55 42 39 26 380
Rupesh Kalidas Shirodkar 122 0.9× 266 2.1× 83 1.5× 59 1.4× 56 1.4× 33 510
R Parikh 166 1.3× 86 0.7× 61 1.1× 93 2.2× 23 0.6× 10 542
Anam Khan 175 1.3× 250 2.0× 114 2.1× 60 1.4× 31 0.8× 10 451
Mallikarjun Chitneni 177 1.3× 214 1.7× 101 1.8× 85 2.0× 24 0.6× 16 502
Yongshan Zhao 173 1.3× 211 1.7× 45 0.8× 37 0.9× 10 0.3× 46 555
Anja Graf 228 1.7× 285 2.3× 75 1.4× 44 1.0× 15 0.4× 11 630
Vamshi Krishna Tippavajhala 79 0.6× 167 1.3× 36 0.7× 33 0.8× 32 0.8× 50 342
J.D. Pipkin 175 1.3× 209 1.7× 39 0.7× 40 1.0× 36 0.9× 34 529
Johannes Parmentier 306 2.3× 318 2.5× 149 2.7× 54 1.3× 12 0.3× 15 742

Countries citing papers authored by Salwa

Since Specialization
Citations

This map shows the geographic impact of Salwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salwa more than expected).

Fields of papers citing papers by Salwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salwa. The network helps show where Salwa may publish in the future.

Co-authorship network of co-authors of Salwa

This figure shows the co-authorship network connecting the top 25 collaborators of Salwa. A scholar is included among the top collaborators of Salwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salwa. Salwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salwa, et al.. (2025). Formulation and evaluation of HPMC and pullulan-based rapidly dissolving films containing cilnidipine nanosuspension. International Journal of Biological Macromolecules. 310(Pt 3). 143329–143329. 4 indexed citations
2.
Salwa, et al.. (2024). Antioxidant and anticancer activities of hesperetin and its novel formulations in KB cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 5213–5236. 3 indexed citations
3.
Bhaskaran, Navya Ajitkumar, Srinivas Reddy Jitta, Salwa, et al.. (2023). Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer. International Journal of Biological Macromolecules. 253(Pt 5). 127142–127142. 22 indexed citations
6.
Jitta, Srinivas Reddy, Salwa, Navya Ajitkumar Bhaskaran, et al.. (2023). Enhanced tissue distribution of ritonavir-loaded nanostructured lipid carriers—recommending its dose reduction. Drug Delivery and Translational Research. 14(1). 116–130. 3 indexed citations
7.
Jitta, Srinivas Reddy, Navya Ajitkumar Bhaskaran, Salwa, & Lalit Kumar. (2022). Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations. AAPS PharmSciTech. 23(4). 88–88. 13 indexed citations
8.
Salwa, et al.. (2022). Implementation of Quality by Design in the Formulation and Development of Nanocarrier-Based Drug Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems. 40(3). 1–46. 6 indexed citations
9.
Bhaskaran, Navya Ajitkumar, et al.. (2022). Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations. International Journal of Biological Macromolecules. 211. 301–315. 34 indexed citations
10.
Bhaskaran, Navya Ajitkumar, et al.. (2022). Development of cream to enhance the antifungal activity and reduce the side effects of fluconazole for the treatment of Candida albicans. Tenside Surfactants Detergents. 59(3). 231–239. 10 indexed citations
11.
Jitta, Srinivas Reddy, et al.. (2021). Development and Validation of High-Performance Liquid Chromatography Method for the Quantification of Remdesivir in Intravenous Dosage Form. Assay and Drug Development Technologies. 19(8). 475–483. 12 indexed citations
12.
Salwa, et al.. (2021). Polymeric microneedles for transdermal delivery of nanoparticles: Frontiers of formulation, sterility and stability aspects. Journal of Drug Delivery Science and Technology. 65. 102711–102711. 43 indexed citations
13.
Salwa & Lalit Kumar. (2021). Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome. Journal of Controlled Release. 338. 837–857. 23 indexed citations
14.
Salwa, et al.. (2019). Enhancement in Dissolution Rate of Atorvastatin Trihydrate Calcium by Formulating Its Porous Tablet Using Sublimation Technique. Journal of Pharmaceutical Innovation. 15(4). 498–520. 26 indexed citations
15.
Salwa, et al.. (2016). Knowledge, attitude and practice of patients with type 2 diabetes mellitus towards complementary and alternative medicine. 14(3). 187–196. 1 indexed citations
16.
Salwa, et al.. (2013). Data Envelopment Analysis Evaluation Framework of Hotel Services. 通讯和计算机:中英文版. 10(2). 193–201. 1 indexed citations
17.
Salwa, et al.. (2012). Molecular Characterization of Olive Cultivars in Iraq Using SSR Markers and Compare with Phenotypic Characterization. 生命科学(ISSN1934-7391). 6(12). 1343–1350. 1 indexed citations
18.
Salwa, et al.. (2011). Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection. 280–288. 3 indexed citations
19.
Ben, et al.. (2010). Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. 世界胃肠病学杂志:英文版(电子版). 3 indexed citations
20.
Khan, Abu T., et al.. (2007). A two-generational reproductive toxicity study of zinc in rats. Journal of Environmental Science and Health Part B. 42(4). 403–415. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026